Impairment of skeletal muscle insulin action with aging in Wistar rats: Role of leptin and caloric restriction

Mechanisms of Ageing and Development

Volumn 133, Issue 5, 2012, Pages 306-316

  De Solís, Alain J ^a   Fernández Agulló, Teresa ^b   García SanFrutos, Miriam ^b   Pérez Pardo, Paula ^a   Bogónez, Elena ^a   Andrés, Antonio ^c   Ros, Manuel ^b   Carrascosa, José M ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b UNIVERSIDAD REY JUAN CARLOS   (Spain)

^c University of Castilla La Mancha   (Spain)

Author keywords

Glucose uptake; Insulin resistance; Leptin; Muscle; P38

Indexed keywords

INSULIN; LEPTIN; PROTEIN TYROSINE PHOSPHATASE 1B; STRESS ACTIVATED PROTEIN KINASE; SUPPRESSOR OF CYTOKINE SIGNALING 3; SYNAPTOPHYSIN;

AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CALORIC RESTRICTION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; EX VIVO STUDY; EXTENSOR DIGITORUM LONGUS MUSCLE; GLUCOSE TRANSPORT; HORMONE BLOOD LEVEL; HORMONE INHIBITION; HYPERLEPTINEMIA; IN VIVO STUDY; INSULIN LIKE ACTIVITY; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; MALE; MOLECULAR EVOLUTION; MUSCLE DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; SOLEUS MUSCLE;

AGING; ANIMALS; CALORIC RESTRICTION; GLUCOSE; INSULIN; INSULIN RESISTANCE; LEPTIN; MALE; MUSCLE, SKELETAL; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 84861233736     PISSN: 00476374     EISSN: 18726216     Source Type: Journal    
DOI: 10.1016/j.mad.2012.03.006     Document Type: Article

References (51)

1. Antonescu C.N., Huang C., Niu W., Liu Z., Eyers P.A., Heidenreich K.A., Bilan P.J., Klip A. Reduction of insulin-stimulated glucose uptake in L6 myotubes by the protein kinase inhibitor SB203580 is independent of p38MAPK activity. Endocrinology 2005, 146:3773-3781.
2. Banks A.S., Davis S.M., Bates S.H., Myers M.G. Activation of downstream signals by the long form of the leptin receptor. J. Biol. Chem. 2000, 275:14563-14572.
3. Basu R., Breda E., Oberg A.L., Powell C.C., Dalla Man C., Basu A., Vittone J.L., Klee G.G., Arora P., Jensen M.D., Toffolo G., Cobelli C., Rizza R.A. Mechanisms of the age-associated deterioration in glucose tolerance. Diabetes 2003, 52:1738-1748.
4. Bjorbaek C., Elmquist J.K., Frantz J.D., Sohelson S.E., Flier J.S. Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol. Cell 1998, 1:619-625.
5. Bjorbaek C., El-Hashimi K., Frantz J.D., Flier J.S. The role of SOCS-3 in leptin signaling and leptin resistance. J. Biol. Chem. 1999, 274:30059-30065.
6. Bonzón-Kulichenko E., Fernández-Agulló T., Moltó E., Serrano R., Fernández A., Ros M., Carrascosa J.M., Arribas C., Martínez C., Andrés A., Gallardo N. Regulation of insulin-stimulated glucose uptake in rat White adipose tissue upon chronic central leptin infusión: effects on adiposity. Endocrinology 2011, 152:1366-1377.
7. Brabant G., Muller G., Horn R., Anderwald C., Roden M., Nave H. Hepatic leptin signaling in obesity. FASEB J. 2005, 19:1048-1050.
8. Buettner C., Pocai A., Muse E.D., Etgen A.M., Myers M.G., Rossetti L. Critical role of STAT3 in leptin's metabolic actions. Cell Metab. 2006, 4:49-60.
9. Carrascosa J.M., Ros M., Andrés A., Fernández-Agulló T., Arribas C. Changes in the neuroendocrine control of energy homeostasis by adiposity signals during aging. Exp. Gerontol. 2009, 49:20-25.
10. Carrascosa J.M., Andrés A., Ros M., Bogónez E., Arribas C., Fernández-Agulló T., De Solís A.J., Gallardo N., Martínez C. Development of insulin resistance during aging: involvement of central processes and role of adipokines. Curr. Prot. Pept. Sci. 2011, 12:305-315.
11. Carvalho C.R.O., Brenelli S.L., Silva A.C., Nunes A.L.B., Velloso L.A., Saad M.J.A. Effect of aging on insulin receptor, insulin receptor substrate-1 and phosphatidylinositol-3 kinase in liver and muscle of rats. Endocrinolgy 1996, 137:151-159.
12. Ceddia R.B., Koistinen H.A., Zierath J.R., Sweeney G. Analysis of paradoxical observations on the association between leptin and insulin resistance. FASEB J. 2002, 16:1163-1176.
13. Eguchi M., Gillis L., Liu Y., Lyakhovsky N., Du M., Mcdermott J., Sweeney G. Regulation of SOCS-3 expression by leptin and ist co-localization with insulin receptor in rat skeletal muscle cells. Mol. Cell. Endocrinol. 2007, 267:38-45.
14. Emanuelli B., Peraldi P., Filoux C., Chavey C., Freidinger K., Hilton D.J., Hotamisligil G.S., Van Obberghen E. SOCS-3 inhibits insulin signaling and is up-regulated in response to tumor necrosis factor-α in the adipose tissue of obese mice. J. Biol. Chem. 2001, 276:47944-47949.
15. Escrivá F., Gavete M.L., Fermín Y., Pérez C., Gallardo N., Alvarez C., Andrés A., Ros M., Carrascosa J.M. Effect of age and moderate food restriction on insulin sensitivity in Wistar rats: role of adiposity. J. Endocrinol. 2007, 194:131-141.
16. Fernández-Galaz C., Fernández-Agulló T., Pérez C., Peralta S., Arribas C., Andrés A., Carrascosa J.M., Ros M. Long-term food restriction prevents ageing-associated central leptin resistance in Wistar rats. Diabetologia 2002, 45:997-1003.
17. Ferrannini E., Vichi S., Beck-Nielsen H., Laakso M., Paolisso G., Smith U., European Group for the Study of Insulin Resistance (EGIR) Insulin action and age. Diabetes 1996, 45:947-953.
18. Fürnsinn C., Brunmair B., Furtmüller R., Roden M., Englisch R., Waldhäusl W. Failure of leptin to affect basal and insulin-stimulated glucose metabolism of rat skeletal muscle in vitro. Diabetologia 1998, 41:524-529.
19. Gabriely I., Ma X.H., Yang X.M., Atzmon G., Rajala M.W., Berg A.H., Scherer P., Rossetti L., Barzilai N. Removal of visceral fat prevents insulin resistance and glucose intolerance of aging. Diabetes 2002, 51:2951-2958.
20. García-San Frutos M., Fernández-Agulló T., De Solís A.J., Andrés A., Arribas C., Carrascosa J.M., Ros M. Impaired central insulin response in aged Wistar rats: role of adiposity. Endocrinology 2007, 148:5238-5247.
21. Harrell N.B., Teachey M.K., Gilford N.J., Henriksen E.J. Essential role of p38 MAPK for activation of skeletal muscle glucose transport by lithium. Arch. Physiol. Biochem. 2007, 113:221-227.
22. Hennige A., Stefan N., Kapp K., Lehmann R., Weigert C., Beck A., Moeschel K., Mushack J., Schleicher E., Häring H.U. Leptin down-regulates insulin action through phosphorylation of serine-318 in insulin receptor substrate 1. FASEB J. 2006, 20:E381-E389.
23. Ho R.C., Fujii N., Witters L.A., Hirshman M.F., Goodyear L.J. Dissociation of AMP-activated protein kinase and p38 mitogen-activated protein kinase signaling in skeletal muscle. Biochem. Biophys. Res. Commun. 2007, 362:354-359.
24. Horrillo D.l.Sierra J., Arribas C., García-San Frutos M., Carrascosa J.M., Fernández-Agulló T., Ros M. Age-associated development of inflammation in Wistar rats: effects of caloric restriction. Arch. Physiol. Biochem. 2011, 117:140-150.
25. Jeong H.W., Hsu K.C., Lee J.W., Ham M., Huh J.Y., Shin H.J., Kim W.S., Kim J.B. Berberine suppresses proinflamatory responses through AMPK activation in macrophages. Am. J. Physio. Endocrinol. Metab. 2009, 296:E955-E964.
26. Kahn B.B., Flier J.S. Obesity and insulin resistance. J. Clin. Invest. 2000, 106:473-481.
27. Kalra S.P. Central leptin gene therapy ameliorates diabetes type 1 and 2 through two independent hypothalamic relays; a benefit beyond weight and appetite regulation. Peptides 2009, 30:1957-1963.
28. Kayali A.G., Austin D.A., Webster N.J. Stimulation of MAPK cascades by insulin and osmotic shock: lack of an involvement of p38 mitogen-activated protein kinase in glucose transport in 3T3-L1 adipocytes. Diabetes 2000, 49:1783-1793.
29. Koch C., Augustine R.A., StegerS.J., Ganjam G.K., Benzler J., Pracht C., Lowe C., Schwartz M.W., Shepherd P.R., Anderson G.M., Grattan D.R., Tups A. Leptin rapidly improves glucose homeostasis in obese mice by increasing hypothalamic insulin sensitivity. J. Neurosci. 2010, 30:16180-16187.
30. Kuma Y., Sabio G., Bain J., Shpiro N., Márquez R., Cuenda A. BIRB796 inhibits all p38 MAPK isoforms in vitro and in vivo. J. Biol. Chem. 2005, 280:19472-19479.
31. Lemieux K., Konrad D., Klip A., Marette A. The AMP-activated protein kinase activator AICAR does not induce GLUT4 translocation to transverse tubules but stimulates glucose uptake and p38 mitogen-activated protein kinases alpha and beta in skeletal muscle. FASEB J. 2003, 17:1658-1665.
32. Minokoshi Y., Haque M.S., Shimazu T. Microinjection of leptin into ventromedial hypothalamus increases glucose uptake in peripheral tissues in rats. Diabetes 1999, 48:287-291.
33. Minokoshi Y., Kim Y.-B., Peroni O.D., Fryer L.G.D., Müller C., Carling D., Kahn B.B. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 2002, 415:339-343.
34. Muller G., Ertj J., Gerl M., Preibisch G. Leptin impairs metabolic actions of insulin in isolated rat adipocytes. J. Biol. Chem. 1997, 272:10585-10593.
35. Pauli J.R., Ropelle E.R., Cintra D.E., De Souza C.T., Da Silva A.S.R., Moraes J.C., Prada P.O., De Almeida Leme J.A.C., Luciano E., Velloso L.A., Carvalheira J.B.C., Saad M.J.A. Acute exercise reverses aged-induced impairments in insulin signaling in rodent skeletal muscle. Mech. Aging Dev. 2010, 131:323-329.
36. Peralta S., Carrascosa J.M., Gallardo N., Ros M., Arribas C. Ageing increases SOCS-3 expression in rat hypothalamus: effects of food restriction. Biochem. Biophys. Res. Commun. 2002, 296:425-428.
37. Pérez C., Fernández-Galaz C., Fernández-Agulló T., Arribas C., Andrés A., Ros M., Carrascosa J.M. Leptin impairs insulin signaling in rat adipocytes. Diabetes 2004, 53:347-353.
38. Ranganathan S., Ciaraldi T.P., Henry R.R., Mudaliar S., Kern P.A. Lack of effect of leptin on glucose transport, lipoprotein lipase and insulin action in adipose and muscle cells. Endocrinology 1998, 139:2509-2513.
39. Ribé D., Yang J., Patel S., Koumanov F., Cushman S.W., Holman G.D. Endofacial competitive inhibition of glucose transporter-4 intrinsic activity by the mitogen-activated protein kinase inhibitor SB203580. Endocrinology 2005, 146:1713-1717.
40. Rouru J., Cusin I., Zakrzewska K.E., Jeanrenaud B., Rohner-Jeanrenaud F. Effects of intravenously infused leptin on insulin sensitivity and on the expression of uncoupling proteins in brown adipose tissue. Endocrinology 1999, 140:3688-3692.
41. Scarpace P.J., Matheny M., Tümer N. Hypothalamic leptin resistance is associated with impaired leptin signal transduction in aged obese rats. Neuroscience 2001, 104:1111-1117.
42. Senn J.J., Klower P.J., Nowak I.A., Zimmer T.A., Koniaris L.G., Furlanetto R.W., Mooney R.A. Suppressor of cytokine signaling-3 (SOCS-3): a potential mediator of interleukin-6 dependent insulin resistance in hepatocytes. J. Biol. Chem. 2003, 278:13740-13746.
43. Serrano R., Villar M., Gallardo N., Carrascosa J.M., Martínez C., Andrés A. The effect of aging on insulin signaling pathway is tissue dependent. Central role of adipose tissue in the insulin resistance of aging. Mech. Aging Dev. 2009, 130:189-197.
44. Somwar R., Perreault M., Kapur S., Taha C., Sweeney G., Ramlal T., Kim D.Y., Keen J., Côte C.H., Klip A., Marette A. Activation of p38 mitogen-activated protein kinase alpha and beta by insulin and contraction in rat skeletal muscle: potential role in the stimulation of glucose transport. Diabetes 2000, 49:1794-1800.
45. Suárez E., Bach D., Cadefau J., Palacin M., Zorzano A., Gumà A. A novel role of neuroregulin in skeletal muscle. Neuroregulin stimulates glucose uptake, glucose transporter translocation, and transporter expression in muscle cells. J. Biol. Chem. 2001, 276:18257-18264.
46. Sweeney G., Keen J., Somwar R., Konrad D., Garg R., Klip A. High leptin levels acutely inhibit insulin-stimulated glucose uptake without affecting glucose transporter 4 translocation in L6 rat skeletal muscle cells. Endocrinology 2001, 142:4806-4812.
47. Wang J.L., Chinookoswong N., Scully S., Qi M., Shi Z.Q. Differential effects of leptin in regulation of tissue glucose utilization in vivo. Endocrinology 1999, 140:2117-2124.
48. Williamson D., Gallagher P., Harber M., Hollon C., Trappe S. Mitogen-activated protein kinase (MAPK) pathway activation: effects of age and acute exercise on human skeletal muscle. J. Physiol. 2003, 547:977-987.
49. Yaspelkis B.B.III, Davis J.R., Saberi M., Smith T.L., Jazayeri R., Singh M., Fernández V., Trevino B., Chinookoswong N., Wang J., Shi Z.Q., Levin N. Leptin administration improves skeletal muscle insulin responsiveness in diet-induced insulin-resistant rats. Am. J. Physiol. Endocrinol. Metab. 2001, 280:E130-E142.
50. Yaspelkis B.B.III, Singh M.K., Krisan A.D., Collins D.E., Kwong C.C., Bernard J.R., Crain A.M. Chronic leptin treatment enhances insulin-stimulated glucose disposal in skeletal muscle of high-fat fed rodents. Life Sci. 2004, 74:1801-1816.
51. Zhu M., De Cabo R., Anson R.M., Ingram D.K., Lane M.A. Caloric restriction modulates insulin receptor signaling in liver and skeletal muscle of rat. Nutrition 2005, 21:378-388.